Tandem Diabetes Care (TNDM) Income towards Parent Company (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Income towards Parent Company for 14 consecutive years, with -$21.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Income towards Parent Company rose 59.52% year-over-year to -$21.2 million; the trailing twelve-month figure through Jun 2026 stood at -$63.3 million (up 69.19% YoY), and the FY2025 full-year result was -$204.7 million, down 113.18% from the prior year.
• Income towards Parent Company eased to -$21.2 million in Q2 2026 per TNDM's latest filing, from -$20.4 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $775000.0 in Q4 2024 and bottomed at -$130.6 million in Q1 2025.
• Historically, Income towards Parent Company has averaged -$36.6 million across 5 years, with a median of -$26.6 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Income towards Parent Company tumbled 951.95% in 2022, then surged 102.59% in 2024.
• Over 5 years, Income towards Parent Company stood at -$15.9 million in 2022, then slumped by 89.03% to -$30.0 million in 2023, then soared by 102.59% to $775000.0 in 2024, then plunged by 170.06% to -$543000.0 in 2025, then slumped by 3806.08% to -$21.2 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$21.2 million, -$20.4 million, and -$543000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.